DE3682664D1 - Mittel zur senkung des dimethylnitrosoaminespiegels. - Google Patents

Mittel zur senkung des dimethylnitrosoaminespiegels.

Info

Publication number
DE3682664D1
DE3682664D1 DE8686309810T DE3682664T DE3682664D1 DE 3682664 D1 DE3682664 D1 DE 3682664D1 DE 8686309810 T DE8686309810 T DE 8686309810T DE 3682664 T DE3682664 T DE 3682664T DE 3682664 D1 DE3682664 D1 DE 3682664D1
Authority
DE
Germany
Prior art keywords
dimethylnitrosoamine
lowering
agent
level
dimethylnitrosoamine level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686309810T
Other languages
English (en)
Inventor
Yasuo Kawai
Nobuo Suegara
Suguru Okazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Advance KK
Original Assignee
Advance KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advance KK filed Critical Advance KK
Application granted granted Critical
Publication of DE3682664D1 publication Critical patent/DE3682664D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE8686309810T 1985-12-19 1986-12-16 Mittel zur senkung des dimethylnitrosoaminespiegels. Expired - Fee Related DE3682664D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60284329A JPH0696538B2 (ja) 1985-12-19 1985-12-19 抗発癌剤

Publications (1)

Publication Number Publication Date
DE3682664D1 true DE3682664D1 (de) 1992-01-09

Family

ID=17677149

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686309810T Expired - Fee Related DE3682664D1 (de) 1985-12-19 1986-12-16 Mittel zur senkung des dimethylnitrosoaminespiegels.

Country Status (4)

Country Link
EP (1) EP0228861B1 (de)
JP (1) JPH0696538B2 (de)
CA (1) CA1322720C (de)
DE (1) DE3682664D1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1723116A1 (ru) * 1988-04-15 1992-03-30 Оренбургский Государственный Медицинский Институт Штамм бактерий BacILLUS SUвтILIS, используемый дл получени препарата дл профилактики и лечени воспалительных процессов и аллергических заболеваний
AU3836489A (en) * 1988-06-09 1990-01-05 Whitecliffe Laboratories Limited Treatment of immunodeficiency
FR2672494A1 (fr) * 1991-02-13 1992-08-14 Madinier Isabelle Ferments prophylactiques favorisant la prevention de la carie dentaire.
US5716615A (en) * 1992-02-10 1998-02-10 Renata Maria Anna Cavaliere Vesely Dietary and pharmaceutical compositions containing lyophilized lactic bacteria, their preparation and use
IT1254210B (it) * 1992-02-10 1995-09-14 Simone Claudio De Composizioni dietetiche e/o farmaceutiche a base di batteri lattici liofilizzati, loro preparazione e impiego
IL101410A0 (en) * 1992-03-29 1992-11-15 Era Masis Ltd Formulation for the treatment of cancer
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
EP1012232B1 (de) 1997-09-10 2009-10-28 Vion Pharmaceuticals, Inc. Genetisch modifizierte, auf tumoren gezielte bakterien mit verminderter virulenz
US6080849A (en) 1997-09-10 2000-06-27 Vion Pharmaceuticals, Inc. Genetically modified tumor-targeted bacteria with reduced virulence
EP0904784A1 (de) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotisches Ernährungspräparat
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
US6962696B1 (en) 1999-10-04 2005-11-08 Vion Pharmaceuticals Inc. Compositions and methods for tumor-targeted delivery of effector molecules
JP4683881B2 (ja) * 2003-08-27 2011-05-18 有限会社アーク技研 抗腫瘍活性剤
RU2373957C2 (ru) 2006-10-13 2009-11-27 Александр Метталинович Тишин Носитель для лекарственных средств и биологически активных веществ для лечения и диагностики и применение его для создания лекарственных средств и способа регулируемой управляемой доставки лекарственного средства или биологически активного вещества с регулируемой десорбцией его
JP2008195673A (ja) * 2007-02-14 2008-08-28 Nippon Meat Packers Inc 延命効果物質、および感染防御効果・ワクチン効果促進物質、前記物質の検定用コンストラクト、並びにそれらの用途
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
CN102548565A (zh) 2009-10-22 2012-07-04 株式会社益力多本社 癌症发病风险降低剂
RU2669024C2 (ru) * 2016-11-22 2018-10-05 Федеральное государственное бюджетное военное образовательное учреждение высшего образования Военно-медицинская академия им. С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ моделирования экспериментального цирроза печени

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52117494A (en) * 1976-03-27 1977-10-01 Morinaga Milk Industry Co Ltd Production of antiiulcer substance
JPS6011686B2 (ja) * 1977-02-26 1985-03-27 善蔵 田村 新規な抗腫瘍剤
JPS55113718A (en) * 1979-02-27 1980-09-02 Yakult Honsha Co Ltd Antitumor agent
GB2072502A (en) * 1980-02-27 1981-10-07 Yakult Honsha Kk Antitumour agent comprising lactobacillus casei
GB2079785B (en) * 1980-04-14 1984-10-03 Kanebo Ltd Process for cultivation of hemolytic streptococcus pyogenes
JPS57175124A (en) * 1981-04-23 1982-10-28 Kyorin Pharmaceut Co Ltd Antitumor drug
JPS59118712A (ja) * 1982-12-27 1984-07-09 Morinaga Milk Ind Co Ltd 抗腫瘍剤及びその製造法
US4678773A (en) * 1983-08-26 1987-07-07 Chugai Seiyaku Kabushiki Kaisha Antitumor agent

Also Published As

Publication number Publication date
JPH0696538B2 (ja) 1994-11-30
EP0228861B1 (de) 1991-11-27
EP0228861A3 (en) 1988-01-13
EP0228861A2 (de) 1987-07-15
CA1322720C (en) 1993-10-05
JPS62145026A (ja) 1987-06-29

Similar Documents

Publication Publication Date Title
FI850106A0 (fi) Ventil.
FI853399A0 (fi) Ventil.
FI871415A0 (fi) Anordning foer kaenslighetsbestaemning av mikroorganismer.
DE3684108D1 (de) Zementformende mittel.
DE3867989D1 (de) Mittel zur verhinderung von staubbildung.
NO860410L (no) Polyorganosiloksan-sammensetninger.
DE3781569D1 (de) Mittel zur oralen verwendung.
DE3682664D1 (de) Mittel zur senkung des dimethylnitrosoaminespiegels.
FI861782A0 (fi) Anordning med justerbar slagkraft pao tangenterna.
FI865020A0 (fi) Anordning foer spetsdragning av pappersbana.
NO871304D0 (no) Snegle-bekjempelsesmiddel.
FI860165A0 (fi) Sidovaegg i en metallurgisk smaeltugn.
DE3682908D1 (de) Fungizides mittel.
NO860409L (no) Polyorganosiloksan-sammensetninger.
DE3769843D1 (de) Mittel zur verhinderung von krustungsbildung.
FI853173L (fi) Vridbar propelleranordning.
FI860895A (fi) Ventil.
NO862887L (no) Fremgangsmaate for bekjempelse av mikroorganismer.
FI874642A0 (fi) Ventil.
FI882247A (fi) Anordning foer infaestning av en kropp.
FI883586A (fi) Anordning foer avtaetning.
DE3676000D1 (de) Baublock.
FI854356A0 (fi) Sjaelvreglerande ventil.
FI861970A (fi) Ventil.
ATE39404T1 (de) Leistungsfoerdernde mittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee